Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
EGL Genetic Diagnostics, |
RCV000790765 | SCV000228627 | pathogenic | not provided | 2012-12-26 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000176869 | SCV000789206 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2B | 2017-01-24 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001232546 | SCV001405108 | pathogenic | Qualitative or quantitative defects of dysferlin | 2019-11-12 | criteria provided, single submitter | clinical testing | This sequence change replaces tryptophan with cysteine at codon 999 of the DYSF protein (p.Trp999Cys). The tryptophan residue is moderately conserved and there is a large physicochemical difference between tryptophan and cysteine. This variant is present in population databases (rs28937581, ExAC 0.02%). This variant has been observed in individual(s) with dysferlinopathies (PMID: 12796534, 15293763, 22849992, 27363342, 27647186, 30366248). ClinVar contains an entry for this variant (Variation ID: 6674). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). For these reasons, this variant has been classified as Pathogenic. |
OMIM | RCV000007059 | SCV000027255 | pathogenic | Miyoshi muscular dystrophy 1 | 2003-06-10 | no assertion criteria provided | literature only | |
Department of Rehabilitation Medicine, |
RCV000176869 | SCV000882776 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2B | 2019-02-11 | no assertion criteria provided | research | The proband has another variant, NM_003494.3: c.779C>G (p.Pro260Arg). |